Advancing Eye Care
For the past 15 years, the Eye Center of Northern Colorado has been on the cutting edge of ophthalmic research to further advance treatments for patients who suffer from glaucoma, retinal diseases, cataracts and other debilitating conditions.
Announcing our Glaucoma/Ocular Hypertension Clinical Study. To learn more click the link below:
What is a clinical trial?
Clinical trials explore whether a medical strategy, treatment or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people.
Why clinical trials?
Clinical trials test new medications, devices and procedures not yet available to the general public. By being part of a clinical trial, participants may receive access to new technologies that wouldn’t be available otherwise, often at no or reduced cost.
As a participant in a clinical trial, patients are also directly helping the development and understanding of new technologies that may offer better care or a cure for sight-threatening and chronic diseases for future patients.
How do I get involved in a clinical trial?
If you suffer from glaucoma, cataracts or another ocular disease, talk to your doctor about the current trials being enrolled and if you would be a good candidate.
The current trials at the Eye Center of Northern Colorado are constantly changing. If you are interested in learning more about our current clinical trials, please contact Courtney Moon at (970) 419-2696 or email: email@example.com
Currently Enrolling Clinical Trials
Please follow the sponsor and clinicaltrials.gov links below to learn more about our studies.
- A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3a Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects with Open-Angle Glaucoma or Ocular Hypertension (OTX-16-002)
Sponsor: Ocular Therapeutix
- The Hydrus Microstent For Refractory Open‐Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)
- Post Approval Study of the CyPass System in Patients with Primary Open Angle Glaucoma Undergoing Cataract Surgery.
- A Prospective, Randomized, Controlled, Multi-Center Clinical Study of the ACRYSOF® IQ Extended Depth of Focus IOL.
- A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (RGN-NK-301).